Press for Imprivata

Today at VMworld 2010, Imprivata®, Inc., the company that simplifies and secures user access, today announced that OneSign 4.5 is fully integrated with the recently released VMware View™ 4.5. The integration provides single sign-on (SSO) and extends strong authenticationcapabilities to enable secure and convenient end-point application access and user roaming desktops in a VMware View 4.5 environment.

Imprivata®, Inc., the company that simplifies and secures user access, announced today that its OneSign® 4.5 solution will be demonstrated at multiple locations throughout the VMworld 2010 Conference taking place in San Francisco from August 30th - September 2nd. OneSign 4.5 will be featured at the Imprivata booth (#441), the VMware booth (#716), the VMware Express booth (#119), as well as inside and outside of the2010 VMware Express Virtualization Truck Tour, which will be making a stop on the show floor before continuing to travel the country. Conference attendees will see firsthand the power that OneSign brings to VMware View™ by enabling secure and convenient end-point application access and user roaming desktops in a virtual desktop environment.

The Zurich Insurance fine that was issued earlier this week has caused much debate on data loss and protection. Omar Hussain, CEO of Imprivata, looks at the issues created because of it. Despite extensive legislation designed to safeguard sensitive information, data losses and unauthorised access to intellectual property are still worryingly commonplace. Consequently, organisations need to have more control and visibility over who is accessing data and where it is being stored.

Imprivata®, Inc., the company that simplifies and secures user access, today announced the formation of its Healthcare Advisory Board. This board draws upon real-world perspectives of industry leaders to address healthcare IT challenges and trends as the company develops innovative and practical solutions that solve the unique challenges facing the healthcare industry. Chaired by Barry P. Chaiken, MD, MPH, FHIMSS, chief medical officer of Imprivata, the Healthcare Advisory Board is comprised of Imprivata customers and industry experts, including: